BREAST
-
Fibrocystic disease of breast (YSR UHS, Nov 2023)
-
Describe the prognostic and predictive factors of breast carcinoma (NTRUHS Dec 2022)
-
Describe the role of core needle biopsies in non-palpable breast lesions (SVIMS April 2022)
-
Discuss the cytology of breast neoplasms (NTRUHS, Nov 2021)
-
Molecular subtypes of breast cancer (NTRUHS, Nov 2021)
-
Discuss prognostic and predictive gene signatures in early stage invasive breast cancer (SVIMS April 2021)
-
Prognostic factors in Carcinoma breast
-
Discuss the differential diagnosis of a lump in the breast in a female aged 30 years
-
Write about complex sclerosing lesions of breast
-
Premalignant conditions of Breast
-
DCIS Breast
-
Lobular carcinoma of breast
-
Prognostic factors of Ca in-situ breast
-
Histological grading of breast carcinoma
-
Status of ER/PR in malignancies
-
Discuss triple negative breast cancer
-
Phyllodes tumor
-
Describe the FNAC of malignant breast neoplasms
-
Describe the general procedure for FNAC. Discuss its usefulness in the diagnosis of various breast lesions.
-
Risk assessment in breast cancer
-
Discuss in detail male breast diseases.
-
Breast implants
-
Discuss the importance of beast FNAC
-
Discuss the role of FNAC in benign malignant tumors of breast
-
Ductal carcinoma in situ
-
Histologic grading of breast carcinoma
-
Discuss the recent concepts in premalignant lesions of breast.
OTHER UNIVERSITY QUESTIONS
-
Role of IHC in breast carcinoma (RGUHS 2018)
-
Role of FNAC in mucinous lesions of breast (RGUHS 2018)
-
Grading of ductal carcinoma in situ (RGUHS MAY 2010)
-
Role of Her2neu in evaluation of breast carcinoma (RGUHS OCT 2010)
-
Discuss the pitfalls in diagnosis of stromal tumor of breast and tumor like lesions interning in diagnosis of breast neoplasm’s (RGUHS OCT 2010)
-
Prognostic factors in breast carcinoma (RGUHS SEP 2007)
-
Discuss the role of intraoperative cytology in the diagnosis of breast lesions (RGUHS MAY 2017)
-
DCIS (RGUHS MAY 2017)
-
Prognostic indicates in carcinoma of breast (RGUHS NOV 2016)
-
Sclerosing lesions of breast-classification and differential diagnosis (JIPMER OCT 2012)
-
Describe in brief the molecular classification of breast cancer and its prognostic and therapeutic significance. Add a note on hereditary familial breast cancer (JIPMER MAR 2014)
-
Classify breast tumors.Discuss the associated common molecular alteration and their prognostic significance (JIPMER OCT 2015)
-
Triple negative breast carcinoma (JIPMER MAR 2012)
-
Differential diagnosis of papillary lesions of breast (JIPMER OCT 2016)
-
Prognostic molecular markers of breast cancer (JIPMER JULY 2016)
-
Write briefly on the role of immunomarkers in the classification and grading of carcinoma of breast. Discuss the various prognostic and predictive factors in breast carcinoma (JIPMER MAR 2013)
-
Molecular markers in breast cancer and scoring assessments (JIPMER MAR 2011)
-
Mammary analog secretory carcinoma (JIPMER OCT 2016)
-
Classification and histopathology of Metaplastic carcinoma of breast. (Manipal Apr 2014)
-
Grading of Ductal carcinoma in situ. (RGUHS May 2010)
-
Discuss the pitfalls in diagnosis of stromal tumors of breast and tumor like lesions intervening in diagnosis of breast neoplasms. (RGUHS Oct 2010)